{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T02:15:29Z","timestamp":1723256129452},"reference-count":34,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T00:00:00Z","timestamp":1247529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> To investigate how delayed introduction of sulfadoxine\u2013pyrimethamine (Fansidar<jats:sup>\u00ae<\/jats:sup>) and arthemeter\u2013lumefantrine (Coartem<jats:sup>\u00ae<\/jats:sup>) as first\u2010line drugs for malaria in KwaZulu\u2010Natal contributed to the reported epidemics of 1985\u20131988 and 1997\u20132001.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Ecological study assessing the association between malaria incidence and the emergence and degree of resistance to chloroquine from 1982 to 1988 and to sulfadoxine\u2013pyrimethamine from 1991 to 2001, when each was the first\u2010line malaria treatment.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The relative risk for malaria infection after the level of drug resistance reached 10% was 4.5 (95% CI: 4.0\u20135.2) in the chloroquine period and 5.9 (95% CI: 5.7\u20136.1) in the sulfadoxine\u2013pyrimethamine period. In the chloroquine period, the relative risk of death from malaria was tenfold (95% CI: 1.3\u201378.1) and the case fatality doubled after drug resistance had reached 10%. The risk of death during the sulfadoxine\u2013pyrimethamine period was 10.8 (95% CI: 5.9\u201319.2) and case fatality 1.8 times higher after drug resistance had reached 10%, than before.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Malaria epidemics in KwaZulu\u2010Natal, South Africa have been exacerbated by failing drug regimens. The establishment of sentinel sites for monitoring drug failure and the prompt adoption of guidelines based on World Health Organization standards in drug resistance should improve malaria control.<\/jats:p>","DOI":"10.1111\/j.1365-3156.2009.02333.x","type":"journal-article","created":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T09:12:16Z","timestamp":1247562736000},"page":"1086-1092","source":"Crossref","is-referenced-by-count":5,"title":["Impact of delayed introduction of sulfadoxine\u2013pyrimethamine and arthemeter\u2013lumefantrine on malaria epidemiology in KwaZulu\u2010Natal, South Africa"],"prefix":"10.1111","volume":"14","author":[{"given":"S. E.","family":"Knight","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. J.","family":"Anyachebelu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Geddes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Maharaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020330"},{"key":"e_1_2_6_3_1","first-page":"970","article-title":"Failure of Sulfadoxine\u2013pyrimethamine in treating Plasmodium falciparum malaria in KwaZulu\u2010Natal","volume":"91","author":"Bredenkamp BL","year":"2001","journal-title":"South African Medical Journal"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1997.0079"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01341.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01340.x"},{"key":"e_1_2_6_7_1","first-page":"394","article-title":"Drug\u2010resistant Plasmodium falciparum malaria in the eastern Transvaal","volume":"84","author":"Deacon HE","year":"1994","journal-title":"South African Medical Journal"},{"key":"e_1_2_6_8_1","volume-title":"Malaria Control Policy KwaZulu\u2010Natal","author":"Department of Health","year":"2000"},{"key":"e_1_2_6_9_1","volume-title":"National HIV and Syphilis Antenatal Sero\u2010prevalence Survey South Africa 2007","author":"Department of Health South Africa","year":"2008"},{"key":"e_1_2_6_10_1","first-page":"968","article-title":"Sentinel malaria surveillance \u2013 more than a research tool","volume":"91","author":"Durrheim DN","year":"2001","journal-title":"South African Medical Journal"},{"key":"e_1_2_6_11_1","first-page":"576","article-title":"In vitro confirmation of chloroquine\u2010resistant Plasmodium falciparum malaria in KwaZulu","volume":"74","author":"Freese JA","year":"1988","journal-title":"South African Medical Journal"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200402200-00023"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(02)00372-9"},{"key":"e_1_2_6_14_1","first-page":"546","article-title":"Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983\u20131988","volume":"76","author":"Hansford CF","year":"1989","journal-title":"South African Medical Journal"},{"key":"e_1_2_6_15_1","first-page":"749","article-title":"In vitro chloroquine\u2010resistant Plasmodium falciparum malaria in the Natal\/KwaZulu area","volume":"68","author":"Herbst JM","year":"1985","journal-title":"South African Medical Journal"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4269\/ajtmh.1986.35.465","article-title":"In vivo efficacy of chloroquine treatment for Plasmodium falciparum in Malawian children under five years of age","volume":"35","author":"Khoromana CO","year":"1986","journal-title":"American Journal Tropical Medicine and Hygiene"},{"key":"e_1_2_6_17_1","volume-title":"Changing national malaria treatment protocols in Africa: what is the cost and who will pay?","author":"Kindermans JM","year":"2002"},{"issue":"2","key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2004.71.187","article-title":"ACT now or later: economics of malaria resistance","volume":"71","author":"Laxminarayan R","year":"2004","journal-title":"American Journal Tropical Medicine and Hygiene"},{"key":"e_1_2_6_19_1","first-page":"871","article-title":"Impact of DDT re\u2010introduction on malaria transmission in KwaZulu\u2010Natal","volume":"95","author":"Maharaj R","year":"2005","journal-title":"South African Medical Journal"},{"key":"e_1_2_6_20_1","volume-title":"Malaria","author":"Moonasar D","year":"2004"},{"key":"e_1_2_6_21_1","volume-title":"The epidemiology of the malaria in KwaZulu, 1980\u20131991","author":"Ngxongo S","year":"1993"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/16.1.1"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/415680a"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2000.00643.x"},{"key":"e_1_2_6_25_1","volume-title":"Mid\u2010year Population Estimates South Africa, 2006","author":"Statistics South Africa","year":"2006"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.64.12"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0764-4469(98)80009-7"},{"key":"e_1_2_6_28_1","first-page":"984","article-title":"In vitro susceptibilities of field isolates of Plasmodium falciparum to Chloroquine in Mpumalanga [letter]","volume":"86","author":"Van Nierop WH","year":"1996","journal-title":"South African Medical Journal"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1999.00435.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02727-6"},{"issue":"1","key":"e_1_2_6_31_1","first-page":"1","article-title":"Combination therapy for .uncomplicated malaria in Africa?","volume":"4","author":"WHO","year":"2001","journal-title":"Liaison Bulletin of the Malaria Programme"},{"key":"e_1_2_6_32_1","volume-title":"Guidelines for the Treatment of Malaria","author":"WHO","year":"2006"},{"key":"e_1_2_6_33_1","volume-title":"Africa Malaria Report","author":"WHO & UNICEF","year":"2003"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czh051"},{"key":"e_1_2_6_35_1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4269\/ajtmh.2003.68.386","article-title":"The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, Western Kenya","volume":"68","author":"Zucker JR","year":"2003","journal-title":"American Journal Tropical Medicine and Hygiene"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3156.2009.02333.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3156.2009.02333.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T18:27:41Z","timestamp":1696962461000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3156.2009.02333.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,24]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-3156.2009.02333.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3156.2009.02333.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,24]]}}}